Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.7 USD | +1.31% | +2.09% | +14.26% |
Apr. 22 | RBC Capital Adjusts Xylem Price Target to $157 From $153 | MT |
Apr. 18 | Oppenheimer Adjusts Price Target on Xylem to $142 From $133, Outperform Rating Kept | MT |
Financials (USD)
Sales 2024 * | 8.5B | Sales 2025 * | 8.97B | Capitalization | 31.6B |
---|---|---|---|---|---|
Net income 2024 * | 823M | Net income 2025 * | 985M | EV / Sales 2024 * | 3.8 x |
Net Debt 2024 * | 703M | Net Debt 2025 * | 105M | EV / Sales 2025 * | 3.54 x |
P/E ratio 2024 * |
38.8
x | P/E ratio 2025 * |
32.8
x | Employees | 23,000 |
Yield 2024 * |
1.1% | Yield 2025 * |
1.18% | Free-Float | 93.17% |
Latest transcript on Xylem Inc.
1 day | +1.31% | ||
1 week | +2.09% | ||
Current month | +1.11% | ||
1 month | +1.13% | ||
3 months | +14.86% | ||
6 months | +45.76% | ||
Current year | +14.26% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Pine
CEO | Chief Executive Officer | 52 | 20-02-29 |
William Grogan
DFI | Director of Finance/CFO | 45 | 23-09-30 |
David Flinton
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Loranger
BRD | Director/Board Member | 72 | 11-10-30 |
Lisa Glatch
BRD | Director/Board Member | 61 | 23-05-23 |
Robert Friel
CHM | Chairman | 68 | 12-12-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.28% | 10 M€ | +6.14% | - | |
0.97% | 1 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 130.7 | +1.35% | 945,656 |
24-04-22 | 129 | +0.89% | 1,061,915 |
24-04-19 | 127.8 | +0.53% | 2,250,015 |
24-04-18 | 127.2 | +0.74% | 1,139,176 |
24-04-17 | 126.2 | -1.39% | 1,441,337 |
Delayed Quote Nyse, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.26% | 31.6B | |
+2.54% | 76.6B | |
+19.47% | 70.68B | |
+17.11% | 36.54B | |
+9.43% | 28.41B | |
+11.24% | 26.88B | |
+5.14% | 26.57B | |
+13.49% | 24.58B | |
+12.01% | 23.67B | |
+5.53% | 16.25B |
- Stock Market
- Equities
- XYL Stock